Order Article Reprints

Rapoport BL, Nayler S, Mlecnik B, Smit T, Heyman L, Bouquet I, Martel M, Galon J, Benn C-A, Anderson R. Tumor-Infiltrating Lymphocytes (TILs) in Early Breast Cancer Patients: High CD3⁺, CD8⁺, and Immunoscore Are Associated with a Pathological Complete Response. Cancers. 2022; 14(10):2525. https://doi.org/10.3390/cancers14102525

Rapoport, Bernardo Leon, Simon Nayler, Bernhard Mlecnik, Teresa Smit, Liezl Heyman, Isabelle Bouquet, Marine Martel, Jérôme Galon, Carol-Ann Benn, and Ronald Anderson. 2022. "Tumor-Infiltrating Lymphocytes (TILs) in Early Breast Cancer Patients: High CD3⁺, CD8⁺, and Immunoscore Are Associated with a Pathological Complete Response" Cancers 14, no. 10: 2525. https://doi.org/10.3390/cancers14102525

Rapoport, B. L., Nayler, S., Mlecnik, B., Smit, T., Heyman, L., Bouquet, I., Martel, M., Galon, J., Benn, C.-A., & Anderson, R. (2022). Tumor-Infiltrating Lymphocytes (TILs) in Early Breast Cancer Patients: High CD3⁺, CD8⁺, and Immunoscore Are Associated with a Pathological Complete Response. Cancers, 14(10), 2525. https://doi.org/10.3390/cancers14102525